You are here

US: Wall Street slips as tech stocks weigh

41511925 - 13_02_2017 - FILES-US-STOCKS-MARKETS-OPEN.jpg

[BENGALURU] US stocks opened lower on Monday, with the Dow on track to snap an 11-day winning streak, as technology stocks declined and investors paused ahead of President Donald Trump's address to a joint session of Congress on Tuesday.

Investors will be closely watching Mr Trump's address for clues on his proposed tax reform and his plans to overhaul the Affordable Healthcare Act.

Mr Trump's promise a few weeks ago of a "phenomenal" tax announcement helped rekindle a post-election rally, driving the main US markets to record highs.

But with details scant on how Mr Trump planned to implement his agenda, investors have turned wary and the markets have traded range-bound.

sentifi.com

Market voices on:

The Dow hit its 11th straight record close on Friday with a mere 0.05 per cent gain.

Utilities and telecom services stocks - traditionally defensive plays of the S&P 500 index - outperformed the other sectors last week.

Billionaire US investor Warren Buffett told CNBC that while stocks are cheap, they are currently unpredictable and prone to a sudden, steep correction.

Also weighing on sentiment was a Commerce Department report that showed new orders for US-made capital goods unexpectedly fell in January after three straight months of strong gains.

At 9.35am ET (1435 GMT) the Dow Jones Industrial Average was down 37.13 points, or 0.18 per cent, at 20,784.63, the S&P 500 was down 4.23 points, or 0.17 per cent, at 2,363.11 and the Nasdaq Composite was down 15.15 points, or 0.26 per cent, at 5,830.15.

Eight of the 11 major S&P 500 sectors were lower, with the 0.33 per cent drop in technology weighing the most. Microsoft was the top drag on the index and fell 0.6 per cent.

Electric carmaker Tesla fell nearly 4 per cent to US$246.42 after Goldman Sachs downgraded the company's stock to"sell" from "neutral" and lowered its price target.

La Jolla Pharmaceutical jumped 47 per cent to US$29.44 following the success of its lead experimental drug in a late-stage study.

Shutterstock dropped 13.4 per cent to US$44.73 after the stock image provider reported quarterly revenue that missed analysts' average estimate.

Declining issues outnumbered advancers on the NYSE by 1,422 to 1,092. On the Nasdaq, 1,214 issues fell and 969 advanced.

The S&P 500 index showed 34 new 52-week highs and one new low, while the Nasdaq recorded 62 new highs and 22 new lows.

REUTERS

Powered by GET.comGetCom